Jounce nix­es Redx of­fer as I/O biotech in­stead goes with Con­cen­tra Bio­sciences’ takeover bid

3 years ago
Financing
Deals

Who’s spend­ing and who’s cut­ting from Big Phar­ma’s $127B R&D bud­get? Here are the top 15 play­ers

3 years ago
R&D
Special

As­traZeneca, Io­n­is boast full PhI­II win for AT­TR drug un­der re­view

3 years ago
R&D

Co­di­ak files for Chap­ter 11 bank­rupt­cy as most ex­ec­u­tives head for the ex­it

3 years ago
People
R&D

An­nounc­ing three ex­cit­ing jour­nal­ists who are join­ing the End­points news­room

3 years ago
Editor's note

Lab­vi­va nets $20M Se­ries A to ease life sci­ence pro­cure­ment process

3 years ago
Financing
Startups

With one of biotech's largest pri­vate rounds in a year, Ar­riVent en­ters PhI­II

3 years ago
Financing
Startups

A ca­reer in can­cer re­search turns out to be the per­fect prep for a gru­el­ing per­son­al ad­ven­ture

3 years ago
Biotech Voices

An­oth­er biotech start­up runs in­to a PhII pile­up in Parkin­son's

3 years ago
R&D

Brain­Storm gets FDA ad­comm for ALS drug af­ter failed tri­al and RTF

3 years ago
R&D
FDA+

Ven­ture in­vest­ing with­out the GSK tie-up? Sime­on George and the SR One team score a $600M fund to pave the way ...

3 years ago
Deals

Lat­est on ul­tra-rare dis­ease ap­proval; Pos­i­tive, if mixed, signs for Bio­gen's ALS drug; Clay Sie­gall finds a new job; ...

3 years ago
Weekly

Up­dat­ed: FDA ap­proves Pharm­ing drug for ul­tra-rare im­mun­od­e­fi­cien­cy dis­ease

3 years ago
R&D
FDA+

Eu­ro­pean doc­tors di­al up dig­i­tal com­mu­ni­ca­tion with phar­mas, but still lean to­ward in-per­son med meet­ings, study ...

3 years ago
Pharma
Marketing

Judge al­lows ex­pert tes­ti­mo­ny in GSK tri­al al­leg­ing Zan­tac link to can­cer

3 years ago
Pharma
Law

Q&A: BioCi­na’s new CEO Mark Wom­ack on the CD­MO he says is 'worth trav­el­ing over'

3 years ago
People
Manufacturing

No­vo Nordisk oral semaglu­tide tri­al shows re­duc­tion in blood sug­ar, plus weight loss

3 years ago
R&D
Pharma

Ab­bott in­tro­duces the Mel­on fam­i­ly to raise con­cus­sion aware­ness

3 years ago
Pharma
Marketing

Sen­ate com­mit­tee ad­vances PBM bill as bi­par­ti­san re­forms gain trac­tion

3 years ago
Pharma
Law

Ly­me vac­cine test com­ple­tion is pushed back by a year as Pfiz­er, Val­ne­va say they'll ad­just tri­al

3 years ago
R&D
Pharma

Stu­art Peltz re­signs as PTC Ther­a­peu­tics CEO af­ter 25 years

3 years ago
People

89bio to net $275M from stock of­fer­ing; As­sem­bly Bio to pause work on one HBV in­hibitor pro­gram

3 years ago
News Briefing

Bet­ter Ther­a­peu­tics cuts 35% of staff while await­ing dig­i­tal ther­a­peu­tic ap­proval

3 years ago
People

Ab­b­Vie says it has pos­i­tive mid-stage da­ta for Rin­voq in lu­pus, will move to PhI­II

3 years ago
R&D
First page Previous page 368369370371372373374 Next page Last page
A service from the Financial Times